A phase I study of the oral administration of irinotecan in combination with the
- This topic has 0 replies, 1 voice, and was last updated 4 years, 11 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
A phase I study of the oral administration of irinotecan in combination with the potent P-glycoprotein (P-gp) inhibitor HM30181A.
http://abstracts.asco.org/239/AbstView_239_264845.html
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.